Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Awada, Ahmad" or (type any "bookEditor journalEditor issueEditor" and editor="Awada, Ahmad")

Add to list
- Journal Article
- A1
- open access
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde (UGent) , Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey (UGent) and Eric Van Cutsem

(2022) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 169.
Add to list
Selective oral MEK1/2 inhibitor pimasertib : a phase I trial in patients with advanced solid tumors

Jean-Pierre Delord, Antoine Italiano, Ahmad Awada, Philippe Aftimos, Nadine Houédé, Céleste Lebbé, Celine Pages, Thierry Lesimple, Monica Dinulescu, Jan H. M. Schellens, et al.

(2021) TARGETED ONCOLOGY. 16(1). p.37-46
Add to list
Selective oral MEK1/2 inhibitor pimasertib in metastatic melanoma : antitumor activity in a phase I, dose-escalation trial

Céleste Lebbé, Antoine Italiano, Nadine Houédé, Ahmad Awada, Philippe Aftimos, Thierry Lesimple, Monica Dinulescu, Jan H. M. Schellens, Suzanne Leijen, Sylvie Rottey (UGent) , et al.

(2021) TARGETED ONCOLOGY. 16(1). p.47-57
Add to list
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Philippe Aftimos, Christian Rolfo, Sylvie Rottey (UGent) , Philippe Barthélémy, Christophe Borg, Keunchil Park, Do-Youn Oh, Sang-We Kim, Natalie De Jonge, Valérie Hanssens, et al.

(2021) BIOMEDICINES. 9(6).
Add to list
- Journal Article
- A1
- open access
Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lueftner, Sylvie Rottey (UGent) , Peter A. van Dam, et al.

(2021) CANCERS. 13(17).
Add to list
- Journal Article
- A1
- open access
On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors

Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey (UGent) , Simon A. J. Rule, David Cunningham, Frederic Peyrade, Christophe Fruchart, Hendrik-Tobias Arkenau, Isabelle Genvresse, et al.

(2020) MOLECULAR CANCER THERAPEUTICS. 19(2). p.468-478
Add to list
- Journal Article
- A1
- open access
Oncological care organisation during COVID-19 outbreak

Concetta Elisa Onesti, Hope S. Rugo, Daniele Generali, Marc Peeters, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Miguel Martin, Massimo Cristofanilli, Javier Cortes, et al.

(2020) ESMO OPEN. 5(4).
Add to list
- Journal Article
- A1
- open access
Brain metastasis and renal cell carcinoma : prognostic scores assessment in the era of targeted therapies

Ziad El Ali, Sylvie Rottey (UGent) , Philippe Barthelemy, Nuria Kotecki, Ruben Van Paemel (UGent) , Daniel Devrient, Ahmad Awada, Thierry Gil, Diane Pannier, Thomas Ryckewaert, et al.

(2019) ANTICANCER RESEARCH. 39(6). p.2993-3002
Add to list
- Conference Paper
- C3
- open access
Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients

David A. Sallman, Jason B. Brayer, Xavier Poire, Violaine Havelange, Ahmad Awada, Philippe Lewalle, Kunle Odunsi, Eunice S. Wang, Caroline Lonez, Thomas Lequertier, et al.

(2019) BLOOD. In Blood 134(Supplement 1).
Add to list
- Conference Paper
- C3
A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types

Bikash Verma, Philippe Georges Aftimos, Ahmad Awada, Jean -Pascal H Machiels, Jason B Brayer, David A Sallman, Tessa Kerre (UGent) , Kunle Odunsi, Caroline Lonez, David Edward Gilham, et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(suppl. 15).

Academic Bibliography

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Selective oral MEK1/2 inhibitor pimasertib : a phase I trial in patients with advanced solid tumors

Selective oral MEK1/2 inhibitor pimasertib in metastatic melanoma : antitumor activity in a phase I, dose-escalation trial

The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors

Oncological care organisation during COVID-19 outbreak

Brain metastasis and renal cell carcinoma : prognostic scores assessment in the era of targeted therapies

Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients

A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types

Contents

Support

Contact